California Public Employees Retirement System Alx Oncology Holdings Inc Transaction History

California Public Employees Retirement System

$147 Billion
Q4 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$52.2 - $75.23 $944,820 - $1.36 Million	-18,100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$62.84 - $87.68 $104,502 - $145,811	-1,663 Reduced 8.41%	18,100 $1.34 Million
Q4 2020 Feb 02, 2021	SELL	$34.11 - $112.26 $13,644 - $44,904	-400 Reduced 1.98%	19,763 $1.7 Million
Q3 2020 Nov 05, 2020	BUY	$29.36 - $47.1 $591,985 - $949,677	20,163 New	20,163 $761,000

Others Institutions Holding ALXO

# of Institutions

Shares Held

39.5M

Call Options Held

213K

Put Options Held

44.8K

Ven Bio Partners LLC San Francisco, CA

9.7M
Shares

$6.89 Million
13.33% of portfolio
Redmile Group, LLC San Francisco, CA

3.69M
Shares

$2.62 Million
0.48% of portfolio
Tang Capital Management LLC San Diego, CA

3.3M
Shares

$2.34 Million
0.41% of portfolio
Black Rock Inc. New York, NY

2.69M
Shares

$1.91 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.5M
Shares

$1.77 Million
0.0% of portfolio

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $28.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account